Analytical Data
-
Gene name
FAM79A
- Application
-
Alternative Names
FAM79A; Mossy fiber terminal-associated vertebrate-specific presynaptic protein; MOVER; Protein FAM79A; TPRG1L; TPRGL_HUMAN; Tumor protein p63-regulated gene 1-like protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5T0D9
-
Expression Region
1-213aa
-
AA Sequence
MLQLRDSVDSAGTSPTAVLAAGEEVGAGGGPGGGRPGAGTPLRQTLWPLSIHDPTRRARVKEYFVFRPGSIEQAVEEIRVVVRPVEDGEIQGVWLLTEREGFGIRIQWDKQSRPSFINRWNPWSTNVPYATFTEHPMAGADEKTASLCQLESFKALLIQAVKKAQKESPLPGQANGVLILERPLLIETYVGLMSFINNEAKLGYSMTRGKIGF
-
Molecular Weight
49.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM79A (family with sequence similarity 79 member A) is a protein that has garnered attention in the fields of molecular biology and genomics due to its potential roles in cellular processes and disease mechanisms. Emerging research suggests that FAM79A is involved in various signaling pathways, particularly those related to cell proliferation, differentiation, and apoptosis. There is increasing interest in its implications in neurological disorders and cancer, where dysregulation of its expression or function may contribute to pathology. The recombinant production of FAM79A protein allows for in-depth analysis of its biochemical properties, including interactions with other biomolecules and its physiological role in cells. By employing techniques such as protein expression in bacterial or mammalian systems, researchers can obtain functional FAM79A for investigative studies. This work is essential not only for understanding the basic biology of FAM79A but also for exploring its potential as a therapeutic target or biomarker in disease contexts. The ongoing elucidation of FAM79A’s structure and function might provide insights into novel treatment strategies and enhance our understanding of complex cellular networks, making it a significant focus of current biological research.
